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Objectives	Myocardial	blood	 flow	(MBF)	 imaging	 is	used	 in	patients	
with	 suspected	 cardiac	 sarcoidosis,	 and	 also	 in	 stress/rest	 studies.	 The	
accuracy	 of	 MBF	 is	 dependent	 on	 imaging	 parameters	 such	 as	 new	
reconstruction	methodologies.	In	this	work,	we	aim	to	assess	the	impact	of	
a	 novel	 PET	 reconstruction	 algorithm	 (Bayesian	 penalized	 likelihood	 –	
BPL)	 on	 the	 values	 determined	 from	 the	 calculation	 of	 	 [13N]-NH3	 MBF	
values.	
Methods.	 Data	 from	 21	 patients	 undergoing	 rest	 MBF	 evaluation	
[13N]-NH3	 as	 part	 of	 sarcoidosis	 imaging	 were	 retrospectively	 analyzed.	
Each	scan	was	reconstructed	with	a	range	of	BPL	coefficients	(1-500),	and	
standard	 clinical	 FBP	 and	 OSEM	 reconstructions.	 MBF	 values	 were	
calculated	via	an	automated	software	routine	for	all	datasets.		
Results.	Reconstruction	 of	 [13N]-NH3	 dynamic	 data	 using	 the	 BPL,	
OSEM,	 or	 FBP	 reconstruction	 showed	 no	 quantitative	 differences	 for	 the	
calculation	 of	 territorial	 or	 global	 MBF	 (p=0.97).	 Image	 noise	 was	 lower	
using	OSEM	or	BPL	reconstructions	than	FBP	and	noise	from	BPL	reached	
levels	 seen	 in	 OSEM	 images	 between	 B=300	 and	 B=400.	 Intra-subject	
differences	 between	 all	 reconstructions	 over	 all	 patients	 over	 all	 cardiac	
territories	showed	a	maximum	coefficient	of	variation	of	9.74%.	
Conclusion.	Quantitation	of	MBF	via	kinetic	modeling	of	cardiac	rest	
MBF	by	[13N]-NH3	is	minimally	affected	by	the	use	of	a	BPL	reconstruction	
technique	with	BPL	images	presenting	with	less	noise.		
	
	
	
Abbreviations:	
OSEM	–	Ordered	subsets	expectation	maximization	
FBP	–	Filtered	back	projection	
BPL	–	Bayesian	Penalized	Likelihood	
MBF	–	Myocardial	blood	flow	
IDIF	–	Image	derived	input	function	
CFR	–	Coronary	Flow	Reserve	
	
Introduction	Quantitative	myocardial	blood	flow	(MBF)	imaging	with	PET	is	utilised	in	many	 centres	 around	 the	 world	 in	 a	 clinical	 setting	 for	 investigation	 of	 the	human	coronary	circulation1-3.	The	technique	allows	the	quantitative	assessment	of	the	distribution	of	flow	for	delineation	of	the	extent	and	severity	of	coronary	artery	 diseases,	 microvascular	 function,	 as	 well	 as	 other	 conditions	 such	 as	cardiac	sarcoidosis.	Radiological	 imaging	detects	cardiac	 involvement	 in	almost	40%	 of	 patients	 with	 sarcoidosis	 and	 is	 more	 sensitive	 than	 ECG,	 Holter	monitoring	 and	 echocardiography4,	 with	 a	 high	 sensitivity	 and	 specificity	reported	 for	 [18F]-FDG	 PET	 of	 89%	 and	 78%	 respectively5.	 Quantification	 of	MBF	has	been	routinely	used	as	an	aid	in	suspected	cardiac	sarcoidosis	in	order	to	 rule	 out	 coronary	 artery	 disease	 or	 to	 identify	 resting	 perfusion	 defects	suggestive	 of	 inflammation-induced	 tissue	 damage6.	 Studies	 have	 also	 shown	that	there	is	a	characteristic	uptake	pattern	in	the	myocardium	of	patients	with	active	cardiac	sarcoidosis7.	“Eyes-to-thighs”	FDG	PET-CT	scanning	is	further	used	to	detect	any	non-cardiac	granulomatous	involvement	(such	as	pulmonary),	with	
atlases	 recently	 published	 showing	 the	 imaging	 features	 and	 patterns8	 and	comprehensive	imaging	protocols	have	also	recently	been	published6.		New	 commercial	 PET	 reconstruction	 algorithms	 are	 continuously	under	development	 and	 investigation,	 with	 their	 operation	 potentially	 affecting	 the	final	 voxel	 values	 presented	 in	 PET	 images.	 Many	 new	 commercial	 methods	include	 data	 corrections	 such	 as	 point-spread	 function	modeling	 of	 the	 entire	PET	 field	 of	 view	 aimed	 at	 improving	 spatial	 resolution	 during	 image	reconstruction	 9,	10.	One	 such	example	of	 this,	 and	of	 interest	 to	 this	work,	 is	 a	new	Bayesian	penalized	likelihood	(BPL)	reconstruction	algorithm	developed	by	GE	 Healthcare	 (commercially	 named	 Q.Clear®).	 The	 technique	 involves	 point-spread-function	modeling	with	noise	modeling	 controlled	 through	 the	use	 of	 a	penalty	 term	 that	 penalizes	 image	 intensity	 differences	 between	 neighboring	pixels.	 The	penalty	 function	 is	 controlled	by	 a	unitless	 ‘beta	 value’	 (henceforth	called	“B”	in	this	work)	which	adjusts	the	strength	of	the	regularizing	term	in	the	objective	 function	 of	 the	 reconstruction11,	 and	 is	 the	 only	 input	 to	 the	reconstruction	 algorithm	 rather	 than	 traditional	 iterations,	 subsets	 and	 post-reconstruction	smoothing	filters	of	iterative	OSEM	algorithms.		The	algorithm	is	allowed	 to	 run	 to	 effective	 convergence,	 allowing	 an	 improved	 quantitative	accuracy	of	imaging	rather	than	suspending	the	algorithm	after	a	certain	number	of	iterations	to	control	the	image	noise.		Previous	 work	 has	 shown	 how	 BPL	 reconstruction	 algorithms	 provide	improved	 signal-to-noise	 (SNR)	 and	 signal-to-background	 ratios	 (SBR)	 in	imaging	of	 colorectal	 liver	metastases12	 lung	nodules13	 	 and	mediastinal	 lymph	nodes14.	 Results	 of	 these	 studies	 showed	 a	 significant	 increase	 in	 average	maximum	 standardized	 uptake	 value	 (SUVmax)	 after	 BPL	 processing.	 Earlier	
work	 has	 focused	 on	 oncology	 [18F]-FDG	 PET	 and	 found	 a	 B	 of	 400	 to	 be	optimum15.	Image	reconstruction	has	been	shown	to	have	an	effect	on	resulting	activity	 concentration	 in	 cardiac	 studies16,	 and	 previous	 work	 has	 shown	differences	 in	 [13N]-NH3	 MBF	 of	 up	 to	 11%	 between	 FBP	 and	 OSEM	reconstructions17.	 MBF	 has	 also	 been	 investigated	 in	 relation	 to	 technological	changes	such	as	2D	and	3D	PET18,	and	on	different	software	packages	for	[13N]-NH3	MBF	calculations19,	although	to	the	best	of	our	knowledge,	no	studies	have	yet	 investigated	the	use	of	new	PSF	reconstruction	methods	 in	dynamic	 [13N]-NH3	 cardiac	 studies,	 or	 investigated	 the	 effects	 of	 different	 B	 value	 for	 these	studies.	 	The	aim	of	 this	study	was	therefore	to	evaluate	the	quantitative	effect	on	 calculated	MBF	 of	 employing	 the	BPL	 algorithm	with	 different	 penalization	factors	on	[13N]-NH3	images	with	a	range	of	B	values	compared	to	our	imaging	standard	of	FBP	reconstruction.		
Methods	
Patients	and	Scanning	Clinical	scans	from	21	patients	(8	female,	13	male,	mean	age	50.4	±	12.5	years)	imaged	for	suspected	cardiac	sarcoidosis	comprising	dynamic	[13N]-NH3	scans	were	 retrospectively	 analyzed..	 No	 selection	 criteria	were	 applied	 to	 the	patients.	 Only	 members	 of	 the	 clinical	 team,	 in	 compliance	 with	 the	 UK	 Data	Protection	 Act,	 reviewed	 patient	 data,	 consequently	 specific	 Research	 Ethics	Approval	 was	 not	 required.	 Patients	 were	 asked	 to	 fast	 for	 12	 hours	 as	 MBF	imaging	 was	 combined	 with	 an	 [18F]-FDG	 viability	 imaging	 study,	 which	required	minimization	of	myocardial	glucose	uptake.	All	data	were	acquired	on	a	GE	Discovery	710	PET-CT	scanner	(GE	Healthcare,	Waukesha,	USA)	at	Site	1	(St	
Thomas’	Hospital,	London,	UK).	BPL	reconstruction	via	QClear	was	not	available	at	Site	1,	thus	RAW	PET	sinograms	and	PET	calibration	files	were	sent	to	Site	2	(Oxford	University	Hospitals,	Oxford,	UK)	for	reconstruction	as	outlined	below.		
[13N]-NH3	imaging	
A	 cine-CT	 was	 acquired	 (100	 kVp,	 10	 mA,	 0.5s	 rotation,	 5.5	 s	 cine	duration,	40	mm	collimation)	for	attenuation	correction,	and	was	reconstructed	to	2.5	mm	contiguous	slices	(704	images).	ECG	gating	was	not	used	for	PET	or	CT	imaging.	Following	the	cine	CT,	patients	were	injected	with	an	average	activity	of	527	±	24	MBq	of	[13N]-NH3	and	3D	PET	was	acquired	in	listmode.	
Attenuation	correction	of	[13N]-NH3	PET	images	was	performed	using	an	average	of	the	acquired	cine	CT,	a	well-published	method	to	correct	for	potential	respiratory	registration	artifacts	 in	[13N]-NH3	cardiac	 imaging	by	matching	CT	and	 PET	 temporal	 resolutions20.	 Owing	 to	 the	 trapping	 in	 cells	 via	 enzymatic	conversion	 of	 ammonia	 to	 glutamate,	 the	 final	 20	 minutes	 of	 the	 26	 minute	acquisition	was	used	to	reconstruct	a	single	static	frame	of	47	slices	(not	part	of	this	analysis),	which	was	then	used	to	determine	the	registration	vector	between	the	 PET	 and	 average	 cine	 CT	 using	 AC.QC	 software	 present	 on	 the	 PET-CT	scanner	 (GE	 Healthcare,	 Waukesha,	 USA).	 CT	 and	 PET	 images	 were	 manually	aligned	to	provide	the	best	visual	registration	and	the	resulting	shift	vector	was	then	applied	to	the	reconstruction	of	the	dynamic	data.	An	experienced	clinician	reviewed	the	images	of	each	registration	as	part	of	a	standard	clinical	protocol.	
List-mode	PET	data	was	re-binned	to	12x10	s,	6x20	s,	2x1	min	and	1x20	min.	Only	the	first	6	minutes	of	data	were	used	for	MBF	calculation.	For	clinical	
reporting	 of	 MBF,	 images	 were	 reconstructed	 at	 Site	 1	 using	 a	 filtered	 back-projection	 (FBP)	 algorithm	 with	 a	 6.4	 mm	 post-smoothing	 filter	 (enhanced	Hanning).	We	 also	 reconstructed	 a	 time-of-flight	 OSEM	 dataset	 (2i24s,	 6.4mm	Gaussian	filter)	for	comparison.	RAW	PET	singrams	and	average	cine	CT	datasets	were	 transferred	 to	 Site	 2,	who	 then	 reconstructed	 the	 sinograms	 acquired	 at	Site	 1	 with	 the	 same	 FBP	 and	 OSEM	 reconstruction	 parameters	 for	 quality	assurance	 (to	 ensure	MBF	 values	were	 equivalent	 from	 both	 sites),	 as	well	 as	performing	BPL	reconstructions	with	B	=	1,	50,	100,	200,	300,	400,	500	(guided	by	earlier	work	in	[18F]-FDG	imaging15)	Site	2	employed	the	normalization,	and	dose	 calibrator	 files	 from	 Site	 1	 required	 for	 image	 reconstruction.	Reconstructed	images	were	then	sent	to	Site	1	for	final	MBF	analysis.	
	
Image	and	Data	Analysis	Myocardial	 blood	 flow	 (MBF)	 values	 were	 calculated	 from	 the	reconstructed	 dynamic	 [13N]-NH3	 data	 using	 SiemensMBF	 software	 (Siemens	Medical	 Solutions,	 Erlangen,	 Germany)	 on	 a	 Syngo	 workstation.	 The	 software	employs	 a	 2-tissue	 compartment	 [13N]-NH3	 kinetic	model	 with	 4	 parameters	(vascular	 volume	 and	 3	 transport	 coefficients)	 describing	 extraction	 and	retention	 of	 [13N]-ammonia	 in	myocardial	 tissue21.	 After	 loading	data	 into	 the	software,	 the	 program	 automatically	 performed	 segmentations	 of	 myocardial	walls	 and	 also	placed	 a	VOI	 in	 the	 left	 ventricle	 for	determination	of	 an	 image	derived	 input	 function	 (IDIF).	 No	 manual	 adjustments	 were	 made	 to	 the	automatically	segmented	volumes.	Values	of	MBF	(ml/min/g)	were	assigned	to	the	 standardized	 American	 Heart	 Association	 (AHA)	 17-segment	 model	 and	
vascular	 territories	 were	 defined	 based	 on	 the	 standard	 division	 of	 the	 polar	map22.		
	
Results	Figure	 1	 shows	 the	 same	 single	 short	 axis,	 vertical	 long	 axis	 and	horizontal	long	axis	slice	from	the	summed	20-minute	images	from	FBP,	and	also	from	increasing	B	 from	BPL	reconstructions.	 Increased	 levels	of	smoothing	can	be	seen	when	increasing	the	B	value.	Figure	2	demonstrates	example	results	of	the	 automated	 segmentation	 procedure	 on	 each	 reconstruction,	 showing	successful	 segmentation	 over	 the	 entire	 range	 of	 B	 values	 independent	 of	 the	levels	of	smoothing	resulting	from	the	reconstruction.		Examples	of	the	image	IDIFs	required	to	drive	the	kinetic	model	used	in	quantification	 software	 are	 shown	 in	 Figure	 3,	 where	 the	 effects	 of	 the	reconstruction	algorithms	on	image	noise	(assessed	by	±1	standard	deviation	of	the	mean	of	 the	 region	of	 interest)	 can	 clearly	be	observed.	Noise	was	 seen	 to	decrease	with	increasing	B,	as	shown	by	example	in	Figure	4,	where	the	standard	deviation	of	a	single	IDIF	has	been	averaged	(using	the	12x10	s	frames	only)	for	a	single	patient.	When	repeated	for	all	patients,	OSEM	levels	of	noise	in	IDIF	and	myocardial	uptake	curves	were	observed	between	B=300	and	B=400.	We	used	FBP	 reconstruction	 as	 a	 gold	 standard,	 as	 is	 common	 in	 dynamic	 cardiac	 PET	imaging	utilizing	kinetic	modeling,	due	to	low	system	bias,	reliable	quantitative	capabilities	 and	 ability	 to	 cater	 for	 rapid	 time	 varying	 changes	 in	 activity	concentration16.	Using	this	methodology,	calculation	of	the	area	under	the	curve	(AUC	 –	 a	 critical	 parameter	 for	 performing	 PET	 compartmental	 kinetic	modeling23)	 of	 the	 input	 function	 for	 all	 reconstructions	 (FBP,	 OSEM,	 B=1,	 50,	100,	 200,	 300,	 400,	 500)	 showed	 a	 maximum	 difference	 over	 all	 patients	 of	
12.2%	lower	with	B=50.	The	cumulative	AUC	is	shown	in	Figure	5.	A	minimum	difference	 over	 all	 patients	 of	 6.1%	 lower	 than	 FBP	 with	 B=400	 in	 the	 case	shown	 was	 determined.	 Although	 FBP	 showed	 a	 consistently	 higher	 AUC,	maximum	 and	minimum	 differences	 in	 AUC	 between	 FBP	 and	 BPL	 algorithms	did	not	correspond	with	any	specific	B	value.		On	 performing	 FBP	 and	 OSEM	 reconstructions	 at	 Site	 1	 and	independently	 for	 the	 same	 reconstructions	 at	 Site	 2,	 automated	 analysis	resulted	in	identical	MBF	values.	This	was	an	important	step	showing	that	RAW	PET	data	was	transferrable,	and	reconstruction	at	Site	2	was	equivalent	in	terms	of	 scanner	 normalization	 files	 and	 corrections,	 and	 therefor	 the	 only	 changes	affecting	the	reconstruction	was	the	implementation	of	the	BPL	algorithm.			MBF	values	 for	 each	vascular	 cardiac	 territory,	 left	 anterior	descending	(LAD),	 left	circumflex	(LCX)	and	right	coronary	artery	(RCX)	as	well	as	a	global	MBF	 values	 were	 automatically	 computed	 by	 the	 kinetic	 modeling	 software.	Overall,	MBF	from	each	patient	using	all	reconstructions	were	closely	correlated,	with	a	 range	of	 coefficient	of	variation	 (CoV)	 from	1.95%	(min)	 -	9.74%	(max)	over	 all	 vascular	 territories	 and	 also	 globally.	 A	 box-plot	 of	 all	 MBF	 values	 is	shown	 in	 Figure	 6.	 One-way	 ANOVA	 results	 comparing	 a	 single	 parameter	(image	 reconstruction)	 in	 each	 vascular	 territory	 (LAD,	 LCX	 and	RCX)	 showed	p>0.95	 for	MBF	 values	 in	 all	 vascular	 territories,	 as	well	 as	 in	 the	 global	MBF,	indicating	 that	 MBF	 values	 from	 all	 reconstructions	 for	 each	 patient	 were	statistically	equivalent.	There	were	also	no	clearly	defined	bias	trends	resulting	from	any	of	the	reconstructions.		We	reconstructed	and	analyzed	all	 images	at	a	128	matrix	as	part	of	the	standard	 clinical	 protocol,	 which	 enabled	 a	 high	 speed	 of	 reconstructing	 21	
dynamic	and	many	static	datasets	 for	each	patient.	However,	we	reconstructed	all	data	for	5	of	the	dynamic	[13N]-NH3	studies	(selected	at	random)	using	a	256	matrix	 in	 order	 to	 investigate	 any	 effect	 on	MBF,	which	 produced	 a	maximum	difference	in	global	MBF	of	3.9%	over	all	5	patients	(2.4%	in	LAD,	2.8%	in	LCX	and	3.1%	in	RCX	over	all	5	datasets	respectively).	Thus	the	matrix	size	of	128	has	only	a	minor	effect	of	 the	 resulting	MBF	values.	None	of	 the	5	patient	datasets	showed	 a	 large	 change	 in	 MBF	 on	 the	 higher	 matrix	 size,	 either	 for	 vascular	territory	or	globally.		
	
	
DISCUSSION	We	 have	 provided	 to	 the	 best	 of	 the	 authors’	 knowledge,	 the	 first	comparisons	of	 a	new	 fully-converged	BPL	 reconstruction	algorithm	on	 [13N]-NH3	cardiac	MBF	values,	showing	that	MBF	quantification	of	the	PET	data	is	not	significantly	affected	over	 the	 range	of	penalization	 factors	of	B=1	 to	B=500	 in	BPL	 reconstruction.	 Images	 such	 as	 those	 shown	 in	 Figure	 1	 show	 increased	smoothing	 at	 higher	 B	 values.	 As	 noted	 in	 previous	 work,	 due	 to	 the	 higher	regularization	 penalty	 factor,	 images	 will	 appear	 smoother	 at	 the	 expense	 of	causing	blurring	of	 the	reconstructed	 images15.	However	as	 shown	 in	Figure	2,	the	automatic	 segmentation	 routine	was	 still	 able	 to	 reproducibly	 segment	 the	myocardium	 from	 the	 images	 throughout	 the	 range	of	 examined	B	values.	The	effects	 of	 the	 increased	 image	 noise	 of	 the	 IDIF	 as	 assessed	 by	 ±1	 standard	deviation	of	the	values	within	the	VOI	shown	in	Figure	3	shows	that	although	the	mean	 IDIF	 is	 consistent	 over	 the	 range	 of	 B	 values,	 the	 standard	 deviation	 on	each	 point	 decreases	with	 increasing	 B	 value.	 Similar	 noise	 relationships	with	increasing	B	were	obtained	for	the	myocardial	uptake	curves	(not	shown).		
	 In	 our	 experience	 of	 using	 a	 commercially	 produced	 MBF	 quantitation	program,	the	software	reports	an	error	value,	although	it	is	the	error	related	to	the	fitting	of	MBF	parameters	resulting	from	the	kinetic	modeling	process	(K1),	and	 is	 not	 inclusive	 of	 the	 noise	 in	 the	 IDIF	 or	 myocardial	 uptake	 curve.	 As	shown	 in	Figure	3	and	Figure	4,	 the	effects	of	 reconstruction	can	cause	a	 large	amount	of	noise	in	the	resulting	VOIs,	and	therefore	should	be	accounted	for	by	any	analysis	software.	However,	as	shown	by	Figure	5	and	Figure	6,	accounting	for	only	 the	 average	 activity	 concentration	and	no	associated	noise	 in	 the	VOI,	both	the	area	under	the	IDIF	and	the	resulting	global	and	territorial	MBF	values	do	 not	 experience	 significant	 changes	with	 increasing	 B	 value.	 For	 the	 patient	with	 a	 maximum	 AUC	 difference	 of	 12.2%	 compared	 to	 standard	 FBP	reconstruction,	this	difference	led	to	a	difference	of	6.3%	in	estimation	of	MBF	in	the	LCX	territory	(0.63	and	0.59	ml/min/g	for	FBP	and	B=400	respectively).		Our	cohort	of	potential	sarcoidosis	patients	did	not	represent	an	optimal	cohort	 to	assess	 the	BPL	reconstructions	 in	 [18F]-FDG	viability	 imaging	due	 to	the	 intentional	 suppression	 of	 physiological	 [18F]-FDG	 uptake	 in	 the	 heart	 in	order	to	minimise	false-positive	results.	In	this	state,	free	fatty	acids	account	for	up	 to	 90%	of	 oxygen	 consumption	 of	 normal	myocytes7,	 and	 this	 technique	 in	patients	without	cardiac	sarcoid	 involvement	produces	 images	primarily	of	 the	blood	 pool,	 with	 poor	 myocardial	 uptake	 of	 FDG,	 except	 in	 cases	 where	sarcoidosis	was	present,	or	in	patients	with	suboptimal	preparation.	However	as	cardiac	[18F]-FDG	imaging	is	normally	only	performed	for	sarcoidosis	purposes	at	 our	 centre,	 patients	 undergoing	 viability	 imaging	 with	 [18F]-FDG	 for	 other	
purposes	 (such	as	 coronary	artery	disease)	 could	be	used	 to	 investigate	 if	 and	how	the	BPL	reconstruction	affects	the	uptake	pattern	of	the	[18F]-FDG.		As	 is	 customary	 in	 clinical	 cardiac	 studies,	 caution	 should	be	 taken	 that	PET	data	 is	 attenuation	 corrected	 and	 respiratory	 corrected	 as	 appropriate,	 as	inaccurate	 attenuation	 correction	 has	 been	 known	 to	 affect	 quantitation	 of	cardiac	 PET	 studies20,	 24.	 This	 study	 focused	 on	 clinically	 acquired	 data	attenuation	corrected	with	an	average	of	a	free-breathing	cine	CT	acquisition	as	recommended	in	ASNC	guidelines25,	however	there	are	many	other	strategies	for	providing	AC	and	also	respiratory	gating26	with	comparisons	of	methods	being	carried	out20,	27.	 	 In	our	work,	all	data	originated	from	the	same	raw	sinograms,	thus	any	motion	affecting	 imaging	would	affect	all	 reconstructions	 in	 the	 same	manner,	 and	 hence	 it	 is	 the	 relative	 difference	 in	 MBF	 that	 was	 of	 interest.	However,	 the	 use	 of	 a	 standardized	 dynamic	 test	 methodology	 to	 examine	differences	 in	 reconstruction	 while	 remove	 the	 confounding	 effects	 of	 motion	artifacts,	and	allowing	a	focus	purely	on	the	kinetic	analysis	would	be	a	welcome	addition	 to	 accurately	 clarify	 a	 comparison	 of	 reconstructions.	 Investigations	with	the	use	of	a	simplistic	non-moving	cardiac	perfusion	phantom	have	recently	been	performed	in	MR	imaging,	and	would	provide	a	useful	standard	by	which	to	compare	 reconstructions	 and	 benchmark	 kinetic	 modeling	 software	 analysis	routines	 free	 from	 the	 considerations	 of	motion	 artifacts28.	 A	 further	 potential	source	of	error	is	the	scanner	being	affected	by	the	high	count	rate	due	to	all	of	the	 [13N]-NH3	activity	being	 in	 the	 field	of	 view	at	 the	 same	 time.	This	would	potentially	increase	the	dead	time	of	some	of	the	PET	detectors	during	the	initial	frames	of	imaging,	affecting	the	input	function	used	to	drive	the	kinetic	model29.	Although	 this	 was	 not	 explicitly	 accounted	 for	 in	 this	 work,	 dead	 time	 would	
have	affected	all	of	 the	reconstructions	 in	 the	same	manner,	and	therefore	was	disregarded	for	this	analysis.			Our	 study	 represents	 preliminary	 data	 investigating	 this	 novel	reconstruction	algorithm,	and	should	be	further	explored	with	a	 larger	dataset.	However,	multi-institutional	comparison	of	PET	MBF	studies	remain	 limited	by	differences	 in	 tracers,	 kinetic	 models,	 technical	 methodology,	 image	 analysis	software,	and	pharmacological	vasodilating	agents1,	3.	For	example,	reported	PET	stress	MBFs	in	normal	individuals	vary	from	1.86	±	0.27	to	5.05	±	0.90	ml/g/min,	with	a	27%	weighted	average	coefficient	of	variation	for	single	measurements30.	Some	standardization	of	MBF	quantification	has	recently	been	performed	by	way	of	 comparing	 image	 analysis	 software	 with	 [82Rb]-Cl31	 or	 [13N]-NH3	 data19	acquired	at	a	single	site.	These	studies	show	good	correlation	between	the	MBF	values	 resulting	 from	 different	 analysis	 packages.	 Options	 for	 improving	methodological	 standardization	 such	 as	 image	 reconstruction	 deserve	 careful	study	and	may	prove	an	important	factor	of	the	overall	ultimate	clinical	utility	of	absolute	MBF	measurements.	Also	of	potential	interest	in	the	future	may	be	the	use	 of	 4D	 parametric	 image	 reconstruction,	 allowing	 the	 reconstruction	 of	parametric	 images	 from	 cardiac	 studies	 directly	 from	 sinograms32,	 33,	 which	potentially	 allow	 motion	 compensation	 along	 with	 a	 better	 estimation	 of	 the	kinetic	 parameters	 than	 the	 traditional	 indirect	 approach	 of	 using	 frame-by-frame	reconstruction	and	curve	fitting	to	regional	time	activity	curves.			
Limitations		 Our	study	has	some	 limitations,	with	 the	 largest	being	 that	we	analyzed	the	results	of	only	21	patients	without	stress	MBF	(and	thus	CFR)	 in	this	small	
study.	However	as	the	image	data	originates	from	the	same	raw	sinogram	data,	the	 effect	 of	 intra-subject	 biological	 variation	 was	 removed.	 Over	 these	 21	patients	we	 showed	a	minor	 influence	of	BPL	 reconstruction	 in	 the	automated	quantification	of	MBF.	Furthermore,	rest	perfusion	imaging	for	sarcoid	diagnosis	is	 a	niche	application	of	MBF	quantification,	 and	efforts	 should	be	 extended	 to	investigate	the	effect	of	the	BPL	reconstruction	with	stress-rest	studies,	and	any	potential	 effect	 on	 the	 variation	 of	 the	 myocardial	 flow	 reserve	 (MFR)	 ratio.	Although	we	expect	 the	 low	coefficient	of	variation	between	reconstructions	to	be	 independent	 of	 flow	 rate,	we	 currently	 lack	 the	 data	 to	 validate	 this	 claim.	Furthermore,	resulting	image	quality	was	not	assessed	in	this	work,	and	such	an	assessment	of	the	blurring	of	high	B	value	images	using	the	BPL	algorithm	may	be	useful	for	identification	of	perfusion	defects.	A	subjective	imaging	score	by	a	trained	 physician	 could	 be	 used	 to	 visually	 compare	 the	 static	 [13N]-NH3	reconstructions	in	terms	of	their	image	quality	rather	than	solely	quantification	of	MBF.	We	have	shown	that	for	MBF	calculations	in	our	dataset,	OSEM	and	FBP	datasets	are	equivalent	and	produce	comparable	values,	as	has	been	shown	by	previous	cardiac	studies	using	 low	count	density	data	 in	[15O]-H2O	and	[18F]-FDG	 studies	 34,	 35,	 and	 at	 rest	 MBF	 values	 (<3.4	 ml/g/min)	 from	 [13N]-NH3	studies17.	However	 for	our	datasets	we	now	extend	 this	equivalency	 to	 include	PSF	modeling	via	the	BPL	reconstruction	algorithm	investigated	in	this	work	as	these	algorithms	begin	to	gain	more	clinical	availability	and	prevalence.			
	
	
Clinical	Relevance	
New	 PET	 reconstruction	 algorithms	 such	 as	 the	 BPL	 technique	 which	allow	 effective	 convergence	 of	 image	 accuracy	 while	 also	 suppressing	 noise	through	 the	 use	 of	 a	 penalization	 factor	 are	 becoming	 more	 commonplace	 in	clinical	PET	 imaging.	However	 the	use	of	 these	reconstruction	 techniques	have	not	 yet	 been	 assessed	 in	 the	 quantification	 of	MBF.	 There	 is	 a	 requirement	 to	demonstrate	 that	 quantification	 of	 MBF	 is	 at	 least	 as	 good	 using	 BPL	reconstruction	 as	 the	 current	 gold	 standard,	which	 due	 to	 linearity	 reasons	 at	highly	changing	activity	concentrations	in	our	case	is	an	FBP	reconstruction.		
	
Conclusions	Our	 work	 from	 this	 study	 shows	 that	 the	 effects	 of	 employing	 a	 BPL	reconstruction	in	[13N]-NH3	cardiac	PET	data	does	not	have	a	significant	effect	on	 the	quantification	of	 rest	MBF	over	all	 cardiac	 territories.	The	 coefficient	of	variation	over	all	reconstructions	was	a	maximum	of	9.74%,	and	the	use	of	the	BPL	algorithm	with	 increasing	B	value	produced	 images	with	 less	 image	noise.	Noise	equivalence	to	standard	OSEM	reconstruction	was	achieved	with	a	B	value	of	300.		
	
	
New	knowledge	gained	Our	 study	 of	 MBF	 in	 21	 patients	 undergoing	 dynamic	 rest	 [13N]-NH3	imaging	showed	that	using	a	PET	reconstruction	algorithm	that	runs	to	effective	convergence	with	noise	suppression,	such	as	the	BPL	algorithm	employed	in	this	work,	does	not	 lead	 to	significant	differences	 in	 the	quantification	of	 rest	MBF.	We	have	also	 identified	 that	 the	BPL	algorithm	with	a	B	value	of	300	gives	 the	same	level	of	noise	in	the	image	as	a	standard	clinically	used	OSEM	algorithm.			
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FIGURES 
 
Figure	 1.	 Slices	 from	 a	 final	 20	 min	 image	 detailing	 comparison	 of	 the	reconstructions	 performed	 including	 FBP,	 OSEM	 (2i,24s)	 and	 BPL	 with	 beta	values	of	1,	200	and	500.	Images	are	displayed	on	the	same	window	widths	and	levels.	A	higher	level	of	smoothing	with	higher	B	values	can	be	observed.	
		
Figure	 2.	 Automatic	 image	 segmentation	 of	 [13N]-NH3	 images	 showing	successful	 segmentation	 for	 all	 reconstructions.	An	automatically	drawn	1x1x1	cm	 volume	 at	 the	 mitral	 valve	 plane	 represents	 the	 position	 of	 the	 left	ventricular	 image	 derived	 input	 function	 (IDIF).	 Images	 are	 displayed	 on	 the	same	window	width	and	level.	
	
	
Figure	3.	Comparison	of	blood	input	functions	automatically	drawn	from	the	left	ventricle	of	a	single	subject	for	four	individual	reconstructions	(FBP,	OSEM,	BPL	B=1	and	B=500).	A	decrease	in	the	noise	(assessed	by	standard	deviation	of	the	mean	of	VOI)	can	be	observed	with	increased	B	value.	
	
Figure	4.	Example	of	a	reduction	 in	 the	standard	deviation	averaged	across	all	10-s	 time	 frames	 of	 an	 IDIF	with	 increasing	 B	 compared	 to	 standard	 FBP	 and	OSEM	reconstructions.	The	image	noise	can	be	observed	to	be	at	OSEM	levels	at	approximately	B=300.			
	
Figure	5.	Example	of	cumulative	area	under	the	IDIF	for	each	reconstruction	for	a	single	patient	using	the	mean	activity	concentrations.	The	maximum	difference	in	 total	area	 from	the	standard	of	FBP	 is	12.2%	(B=50	–	and	 the	 largest	 in	 the	entire	 study),	 and	 the	 minimum	 is	 6.1%	 (OSEM).	 The	 maximum	 difference	 in	AUC	 for	 each	 patient	 did	 not	 correspond	 with	 any	 specific	 reconstructed	algorithm.		
	Figure	 6.	 Global	 and	 territorial	 MBF	 results	 from	 all	 patients	 (1-10)	 with	 all	reconstructions.	The	resulting	MBF	values	for	each	patient	are	closely	correlated	with	 a	 maximum	 coefficient	 of	 variation	 of	 9.74%	 over	 all	 patients	 and	territories.										
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